AN INACTIVE CYTOCHROME-P450 CYP2D6 ALLELE CONTAINING A DELETION AND A BASE SUBSTITUTION

被引:2
作者
DALY, AK [1 ]
LEATHART, JBS [1 ]
LONDON, SJ [1 ]
IDLE, JR [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,DIV OCCUPAT & PUBL HLTH,LOS ANGELES,CA 90033
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cytochrome P450 CYP2D6 is a polymorphic enzyme, for which 5%-10% of Caucasians (poor metabolizers) lack activity. The majority of mutations giving rise to the deficiency have now been identified but some individuals show anomalous phenotype-genotype relationships when screened for the common mutant alleles. We have sequenced all nine exons and intron-exon boundaries in a subject who was phenotypically a poor metabolizer but genotypically heterozygous when screened for the common alleles. A single base-pair deletion (T-1795) was detected in exon 3 and a base substitution (G(2064)A) resulting in an amino acid substitution (G(212)E) in exon 4. The deletion results in premature termination of translation and a truncated protein. Tn a group of 50 white Americans, the allele frequency for the new mutant allele was 0.01. The new allele explains some cases of anomalous genotype/phenotype relationships for CYP2D6.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 11 条
[1]  
ARMSTRONG M, 1994, PHARMACOGENETICS, V4, P47
[2]   DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].
BROLY, F ;
GAEDIGK, A ;
HEIM, M ;
EICHELBAUM, M ;
MORIKE, K ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558
[3]   ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION [J].
DAHL, ML ;
JOHANSSON, I ;
PALMERTZ, MP ;
INGELMANSUNDBERG, M ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :12-17
[4]   GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES [J].
DALY, AK ;
ARMSTRONG, M ;
MONKMAN, SC ;
IDLE, ME ;
IDLE, JR .
PHARMACOGENETICS, 1991, 1 (01) :33-41
[5]   METABOLIC POLYMORPHISMS [J].
DALY, AK ;
CHOLERTON, S ;
GREGORY, W ;
IDLE, JR .
PHARMACOLOGY & THERAPEUTICS, 1993, 57 (2-3) :129-160
[6]  
EVANS WE, 1991, PHARMACOGENETICS, V1, P143
[7]  
KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209
[8]  
KIMURA S, 1989, AM J HUM GENET, V45, P889
[9]  
Sambrook J., 1989, MOL CLONING LAB MANU
[10]   MOLECULAR-BASIS OF GENETIC-VARIATION IN DEBRISOQUIN HYDROXYLATION IN CHINESE SUBJECTS - POLYMORPHISM IN RFLP AND DNA-SEQUENCE OF CYP2D6 [J].
WANG, SL ;
HUANG, JD ;
LAI, MD ;
LIU, BH ;
LAI, ML .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (04) :410-418